Search

everythinglearnresearchcommunity

for

Search:↓

Botulinum toxin may reduce inflammation markers in head and neck conditions, but evidence is uncertain.

Runx1 and CDK inhibitors help keep hair follicle stem cells inactive, affecting their future roles.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Women with PCOS have higher renin and d-dimer levels, especially if they have COVID-19.

High-intensity interval training improves certain hormone levels and lipid profiles in women with PCOS.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Men with androgenetic alopecia may have higher cholesterol and triglycerides.

Higher Alarin levels may predict androgenetic alopecia and metabolic syndrome.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Women with early onset androgenetic alopecia have worse lipid profiles.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Lower testosterone levels in men may be linked to a higher risk of severe coronary artery disease.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Mild essential fatty acid deficiency can cause health issues and is worsened by low-fat diets.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

People with plantar corns and calluses may have a higher chance of having metabolic syndrome.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

Clove leaf extract lowers bad cholesterol and increases good cholesterol while also increasing body weight.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Finasteride effectively treats baldness but may cause sexual side effects.

Various treatments exist for hair loss, but more research is needed for better options.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

Experts created guidelines for treating hair loss in Egypt, focusing on personalized care.

Ziziphus spina-christi leaf extract lowered blood sugar and protected organs in diabetic rats.